Overview

Temsirolimus and Radiation for Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To determine the maximum tolerated dose of the drug temsirolimus given with radiation therapy for patients with non-small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Everolimus
Sirolimus